Rare cancer registry launches to unlock secrets of MLA
NCT ID NCT06377527
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times
Summary
This study is creating a database of medical information from 2,000 people with mesonephric-like adenocarcinoma (MLA), a very rare type of uterine cancer. Researchers hope to learn more about how MLA behaves and what makes it different from other cancers. No treatments or tests are given—participants simply allow their existing medical records to be used for research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MESONEPHRIC-LIKE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.